BOTOX® Intravesical Instillation in Participants With Overactive Bladder and Urinary Incontinence

Completed · Phase 2 · Has a placebo group

Conditions studied: Urinary Incontinence, Overactive Bladder With Urinary Incontinence

In brief

This study will evaluate the efficacy and safety of BOTOX® intravesical instillation in participants with overactive bladder and urinary incontinence.

Key facts

Study ID
NCT03320850
Run by
Allergan
People needed
383
Starts
2017-10-04
Expected to finish
2020-07-21
Last updated by the study team
2021-08-13

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.